510 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

0Y5E

Perrigo
US$25.61-2.3%-22.7%US$3.6bUS$38.77PE4362.3xE49.3%4.3%

0HI3

Arrowhead Pharmaceuticals
US$27.6916.3%-23.2%US$3.4bUS$53.29PS95.4xE40.3%n/a

0RD1

Camurus
kr577.913.3%115.3%kr34.2bkr615.02PE76xE55.7%n/a

CAMXS

Camurus
kr547.500%n/akr34.2bkr582.66PE76xE55.7%n/a

0I3Q

Corcept Therapeutics
US$30.455.7%40.9%US$3.2bUS$49.47PE27.2xE26.0%n/a

VIRPP

Virbac
€362.000%n/a€2.9b€386.13PE24.2xE11.2%0.4%

0NM7

Virbac
€349.000.4%29.7%€2.9b€372.27PE24.2xE11.2%0.4%

HCM

HUTCHMED (China)
UK£2.81-2.4%56.8%UK£2.4bUK£4.71PE30.2xE18.9%n/a

0HQ1

Azenta
US$56.581.0%27.5%US$3.0bUS$64.44PS4.5xE83.8%0%

0HF9

Amicus Therapeutics
US$9.89-1.3%-23.2%US$3.0bUS$17.40PS6.9xE60.9%n/a

0NDV

MorphoSys
€67.480.7%157.0%€2.5b€58.69PS10.5xE67.3%n/a

MORD

MorphoSys
€66.700%n/a€2.5b€57.93PS10.5xE67.3%n/a

0IV3

Geron
US$4.645.9%54.2%US$2.7bUS$7.12PS5155.7xE65.1%n/a

0VGI

TG Therapeutics
US$18.9113.7%-16.3%US$2.6bUS$31.04PE66.7xE48.0%n/a

0A4W

ACADIA Pharmaceuticals
US$15.777.4%-34.0%US$2.6bUS$27.45PS3.2xE41.8%n/a

0HB0

Agios Pharmaceuticals
US$45.818.7%65.1%US$2.6bUS$54.16PS86.3xE19.5%n/a

GLPGA

Galapagos
€32.190%-24.5%€2.3b€36.71PS4.2xE4.2%n/a

0JBU

Intellia Therapeutics
US$25.020.9%-39.8%US$2.4bUS$70.76PS45.8xE33.4%n/a

BIOABS

BioArctic
kr279.800%-0.1%kr23.8bkr382.74PE92.2xE46.7%0%

0A88

10x Genomics
US$19.841.0%-63.6%US$2.4bUS$39.85PS3.8xE63.5%n/a

0YAY

Vitrolife
kr179.304.7%-13.3%kr24.2bkr232.05PS6.9xE105.7%0.6%

VITRS

Vitrolife
kr165.800%-20.0%kr24.2bkr214.58PS6.9xE105.7%0.6%

0JDK

Iovance Biotherapeutics
US$8.001.6%4.6%US$2.3bUS$25.25PS1199.3xE64.5%n/a

INDVL

Indivior
UK£13.504.8%-25.2%UK£1.8bUK£24.77PE446.1xE34.7%0%
Page 7 of 22
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.